touchMDT for touchONCOLOGY

Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.

The multidisciplinary team

• Dermato-oncologist: Dr Joël Claveau, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management

touchMDT for touchONCOLOGY

Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.

The multidisciplinary team

• Radiation oncologist: Dr Agata Rembielak, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management  

touchMDT for touchONCOLOGY

Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.

The multidisciplinary team

• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management  

touchMDT for touchNEUROLOGY

Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA     

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/

touchMDT for touchNEUROLOGY

Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services 

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/

touchMDT for touchNEUROLOGY

Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/

touchMDT for touchRESPIRATORY

Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA     

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/

touchMDT for touchRESPIRATORY

Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services 

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/

touchMDT for touchNEUROLOGY

Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers

The experts

• Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.